BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• 

  C-suite

  GSK CEO Emma Walmsley Gets Pay Bump To Align With Pharma Peers

  One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 million in 2025.

  February 27, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Syantra and Mays Cancer Center at UT Health San Antonio collaborate on clinical studies with new funding award

  February 27, 2025

   · 

  2 min read
• Press Releases

  Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

  February 27, 2025

   · 

  3 min read
• Press Releases

  NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update

  February 27, 2025

   · 

  21 min read
• Press Releases

  Madrigal Announces New Two-Year Data from the Compensated MASH Cirrhosis Arm of the MAESTRO-NAFLD-1 Trial Demonstrating Potential Benefit of Rezdiffra™ (resmetirom) in Patients with Compensated MASH Cirrhosis

  February 27, 2025

   · 

  13 min read
• Press Releases

  Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis

  February 27, 2025

   · 

  8 min read
• Press Releases

  Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025

  February 27, 2025

   · 

  2 min read
• Press Releases

  Immunocore reports fourth quarter and full year 2024 financial results and provides a business update

  February 27, 2025

   · 

  29 min read
• Press Releases

  Kymera Therapeutics to Participate in Upcoming March 2025 Investor Conferences

  February 27, 2025

   · 

  1 min read
• Press Releases

  IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19

  February 27, 2025

   · 

  7 min read